These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3358106)

  • 41. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Totally implantable venous access ports--the patients' point of view. A quality control study.
    Borst CG; de Kruif AT; van Dam FS; de Graaf PW
    Cancer Nurs; 1992 Oct; 15(5):378-81. PubMed ID: 1423257
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Future dimensions in vascular access--peripheral implantable ports.
    McKee J
    J Intraven Nurs; 1991; 14(6):387-93. PubMed ID: 1748920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Totally implantable catheters. Experience at the University Hospital Center Vaudois from March 1984 to December 1987].
    Amrein E; Leyvraz S; Genton A; Pettavel J; Beck D
    Helv Chir Acta; 1989 Jun; 56(1-2):289-93. PubMed ID: 2777615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence and management of catheter occlusion in implantable arm ports: results in 391 patients.
    Whigham CJ; Greenbaum MC; Fisher RG; Goodman CJ; Thornby JI; Thomas JW
    J Vasc Interv Radiol; 1999 Jun; 10(6):767-74. PubMed ID: 10392945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management and prevention of complications of subcutaneous intravenous infusion port.
    Jan HC; Chou SJ; Chen TH; Lee CI; Chen TK; Lou MA
    Surg Oncol; 2012 Mar; 21(1):7-13. PubMed ID: 20674336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical application of a totally implantable catheter system].
    Dahl HD; Hengstmann JH; Bode U; Hansen H
    Dtsch Med Wochenschr; 1986 Jan; 111(3):88-92. PubMed ID: 3940846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implantable catheter system for long-term intravenous chemotherapy.
    Hall P; Cedermark B; Swedenborg J
    J Surg Oncol; 1989 May; 41(1):39-41. PubMed ID: 2716332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of port-a-cath in cancer patients: a single-center experience.
    D'Souza PC; Kumar S; Kakaria A; Al-Sukaiti R; Zahid KF; Furrukh M; Burney IA; Al-Moundhri MS
    J Infect Dev Ctries; 2014 Nov; 8(11):1476-82. PubMed ID: 25390061
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Implantable catheter system for ambulatory parenteral antibiotic chemotherapy. A prospective study].
    Laffer U; Dürig M; Zimmerli W; Stoll HR; Landmann J
    Helv Chir Acta; 1989 Jun; 56(1-2):127-31. PubMed ID: 2777591
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical experience with bacterial contamination of Port-A-Cath systems in tumor patients].
    Fuchs R; Leimer L; Koch G; Westerhausen M
    Dtsch Med Wochenschr; 1987 Oct; 112(42):1615-8. PubMed ID: 3665749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Totally implantable venous access devices via subclavian vein: a retrospective study of 368 oncology patients.
    Ozyuvaci E; Kutlu F
    Adv Ther; 2006; 23(4):574-81. PubMed ID: 17050500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Completely implantable venous access systems. A study of the morbidity and benefits of a model third-generation device, the PAS Port with Cath-Finder].
    Miguelena Bobadilla JM; Sousa Domínguez R; Güemes Sánchez A; Cabezali Sánchez R; Gil Romea I; Palacín García-Valiño R; Burdio Pinilla F
    Nutr Hosp; 1995; 10(2):99-103. PubMed ID: 7756397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New implantable device for long-term vascular access in children.
    Reinberg O; Beck D
    Eur J Pediatr Surg; 1992 Jun; 2(3):183-5. PubMed ID: 1498114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Complications of an intravenous administration system (Port-A-Cath) in children with an oncologic disease].
    van de Graaf SA; Voûte PA; Vos A
    Ned Tijdschr Geneeskd; 1995 Apr; 139(16):830-3. PubMed ID: 7731475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Central venous catheter with subcutaneous injection port (Port-A-Cath): clinical experience with children.
    Wesenberg F; Anker C; Sommerschild H; Flaatten H
    Pediatr Hematol Oncol; 1987; 4(2):137-43. PubMed ID: 3155237
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of an implantable venous access system in a general oncology population.
    Barrios CH; Zuke JE; Blaes B; Hirsch JD; Lyss AP
    Oncology; 1992; 49(6):474-8. PubMed ID: 1465287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new peripherally implanted subcutaneous permanent central venous access device for patients requiring chemotherapy.
    Salem RR; Ward BA; Ravikumar TS
    J Clin Oncol; 1993 Nov; 11(11):2181-5. PubMed ID: 8229132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Totally implantable system for peritoneal access.
    Pfeifle CE; Howell SB; Markman M; Lucas WE
    J Clin Oncol; 1984 Nov; 2(11):1277-80. PubMed ID: 6491705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of totally implantable vascular access port with mini-invasive Seldinger technique in 12 dogs undergoing chemotherapy.
    Valentini F; Fassone F; Pozzebon A; Gavazza A; Lubas G
    Res Vet Sci; 2013 Feb; 94(1):152-7. PubMed ID: 22921371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.